Pulse Biosciences (PLSE) Cash & Equivalents (2015 - 2026)
Pulse Biosciences' Cash & Equivalents came in at $101.62 million for Q2 2026, down 4.4% from $106.35 million a year earlier.
Powered by 
Analysis
Pulse Biosciences (PLSE) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Pulse Biosciences' Cash & Equivalents was $80.74 million, down 31.6% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 45.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $118.04 million in FY2024 (+166.1%), $44.37 million in FY2023 (-27.4%), $61.14 million in FY2022 (+37.8%) and $44.37 million in FY2021 (+256.0%).
- The five-year range for quarterly Cash & Equivalents is $12.68 million (Q1 2022) to $119.28 million (Q1 2025).
- Year-over-year, Cash & Equivalents increased in five of the last seven quarters, with growth averaging 107.9%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 493.9%), and the weakest in Q1 2022 (a decline of 78.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Pulse Biosciences | 3.39 Bn | 3.39 Bn | 161,000.00 | 101.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.62 Mn |
| Dec 31, 2025 | 80.74 Mn |
| Sep 30, 2025 | 95.21 Mn |
| Jun 30, 2025 | 106.35 Mn |
| Mar 31, 2025 | 119.28 Mn |
| Dec 31, 2024 | 118.04 Mn |
| Sep 30, 2024 | 79.03 Mn |
| Jun 30, 2024 | 26.20 Mn |
| Mar 31, 2024 | 34.90 Mn |
| Dec 31, 2023 | 44.37 Mn |
| Sep 30, 2023 | 50.39 Mn |
| Jun 30, 2023 | 58.75 Mn |
| Mar 31, 2023 | 54.10 Mn |
| Dec 31, 2022 | 61.14 Mn |
| Sep 30, 2022 | 69.16 Mn |
| Jun 30, 2022 | 14.80 Mn |
| Mar 31, 2022 | 12.68 Mn |
| Dec 31, 2021 | 44.37 Mn |
| Sep 30, 2021 | 41.99 Mn |
| Jun 30, 2021 | 47.43 Mn |
API Access
Pulse Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLSE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PLSE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLSE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();